Inactivating germline mutations in EGLN1 have been identified to cause erythrocytosis [13],[14] and deregulation of EGLN3 has been linked to the development of pheochromocytoma, a neuroendocrine tumor of the adrenal glands [15]. Here, EGLN3 is linked to pheochromocytoma.